Etomidate
- Generic Name
- Etomidate
- Brand Names
- Amidate
- Drug Type
- Small Molecule
- Chemical Formula
- C14H16N2O2
- CAS Number
- 33125-97-2
- Unique Ingredient Identifier
- Z22628B598
- Background
Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic.
- Indication
Used in the induction of general anesthesia.
- Associated Conditions
- -
- Associated Therapies
- General Anesthesia
Anesthesia for Upper Endoscopy and Colonoscopy in Cardiac Patients With Acute Anemia
- Conditions
- Interventions
- First Posted Date
- 2021-04-23
- Last Posted Date
- 2021-04-23
- Lead Sponsor
- King Saud University
- Target Recruit Count
- 60
- Registration Number
- NCT04857450
- Locations
- 🇸🇦
King Khalid University Hospital, Riyadh, Saudi Arabia
Prospective Study of Induction Medications Used in the Trauma RSI
- Conditions
- Interventions
- First Posted Date
- 2020-03-02
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 7000
- Registration Number
- NCT04291521
- Locations
- 🇺🇸
Keck School of Medicine of the University of Southern California, Los Angeles, California, United States
Spontaneous and Oxytocin-induced Contractility After Exposure to Intravenous Anesthetic Agents: an In-vitro Study in Human Myometrium
- Conditions
- Interventions
- First Posted Date
- 2019-02-25
- Last Posted Date
- 2022-10-25
- Target Recruit Count
- 33
- Registration Number
- NCT03852797
- Locations
- 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada
Evaluating the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation
- First Posted Date
- 2018-06-04
- Last Posted Date
- 2021-11-26
- Target Recruit Count
- 428
- Registration Number
- NCT03545503
- Locations
- 🇺🇸
New Hanover Regional Medical Center, Wilmington, North Carolina, United States
Hyperventilation Combined With Etomidate or Ketamine Anesthesia in ECT Treatment of Major Depression
- Conditions
- Interventions
- First Posted Date
- 2016-10-05
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- University of Manitoba
- Target Recruit Count
- 48
- Registration Number
- NCT02924090
- Locations
- 🇨🇦
Health Sciences Centre, Winnipeg, Manitoba, Canada
Etomidate to Improve Outcome in Elderly Patients
- Conditions
- Interventions
- First Posted Date
- 2016-09-21
- Last Posted Date
- 2020-12-10
- Lead Sponsor
- Zhihong LU
- Target Recruit Count
- 1917
- Registration Number
- NCT02910206
- Locations
- 🇨🇳
Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China
General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke
- Conditions
- Interventions
- First Posted Date
- 2016-07-04
- Last Posted Date
- 2023-05-23
- Lead Sponsor
- Rennes University Hospital
- Target Recruit Count
- 351
- Registration Number
- NCT02822144
- Locations
- 🇫🇷
Fédération d'anesthésie-réanimation - Hôpital Pontchaillou, CHU de Rennes, Rennes, France
🇫🇷Service d'anesthésie-réanimation - Fondation A. de Rothschild, Paris, France
🇫🇷Département d'anesthésie-réanimation - Hôpital de la Cavale Blanche, CHU de Brest, Brest, France
Rocuronium Consumption in Etomidate-based and Propofol-based General Anesthesia Under Sevoflurane
- Conditions
- Interventions
- First Posted Date
- 2016-03-17
- Last Posted Date
- 2016-03-17
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 175
- Registration Number
- NCT02711917
Neurorestorative Effects of Electroconvulsive Therapy (ECT) in Patients With Severe Late Life Depression
- Conditions
- Interventions
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2016-01-28
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Target Recruit Count
- 110
- Registration Number
- NCT02667353
Target Controlled Infusion of Etomidate or Propofol for Anesthesia of Thoracoscopic Mitral Valve Replacement Surgery
- First Posted Date
- 2016-01-01
- Last Posted Date
- 2016-01-01
- Lead Sponsor
- Xijing Hospital
- Target Recruit Count
- 110
- Registration Number
- NCT02644980
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.